These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27721341)

  • 41. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
    Skrdla PJ; Zhang D
    J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
    Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
    Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Molecules; 2015 Oct; 20(10):19571-87. PubMed ID: 26516832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
    Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
    Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
    Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Dudognon E; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2016 Feb; 499(1-2):67-73. PubMed ID: 26707413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.
    Pan X; Julian T; Augsburger L
    AAPS PharmSciTech; 2006 Mar; 7(1):E72-E78. PubMed ID: 28290026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
    Sovago I; Wang W; Qiu D; Raijada D; Rantanen J; Grohganz H; Rades T; Bond AD; Löbmann K
    Molecules; 2016 Apr; 21(4):509. PubMed ID: 27104502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry.
    Siddiqui A; Rahman Z; Bykadi S; Khan MA
    J Pharm Sci; 2014 Sep; 103(9):2819-2828. PubMed ID: 24585357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adding a New Dimension to the Amorphous Solid Dispersion Phase Diagram: Studying Dissolution Kinetics of Crystalline Drugs in a Polymer Matrix Using Temperature Dependent XRPD and DSC.
    Seiler VK; Theil F; Nagel N; van Lishaut H
    J Pharm Sci; 2022 Sep; 111(9):2496-2504. PubMed ID: 35405124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an analytical method for crystalline content determination in amorphous solid dispersions produced by hot-melt extrusion using transmission Raman spectroscopy: A feasibility study.
    Netchacovitch L; Dumont E; Cailletaud J; Thiry J; De Bleye C; Sacré PY; Boiret M; Evrard B; Hubert P; Ziemons E
    Int J Pharm; 2017 Sep; 530(1-2):249-255. PubMed ID: 28746834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.
    Burnett DJ; Khoo J; Naderi M; Heng JY; Wang GD; Thielmann F
    AAPS PharmSciTech; 2012 Dec; 13(4):1511-7. PubMed ID: 23135965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.
    Jensen KT; Larsen FH; Cornett C; Löbmann K; Grohganz H; Rades T
    Mol Pharm; 2015 Jul; 12(7):2484-92. PubMed ID: 26057950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and investigation of the vibrational properties of crystalline and co-amorphous drugs with Raman and terahertz spectroscopy.
    Liu W; Liu Y; Huang J; Lin Z; Pan X; Zeng X; Lamy de la Chapelle M; Zhang Y; Fu W
    Biomed Opt Express; 2019 Aug; 10(8):4290-4304. PubMed ID: 31453011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The quantitative analysis of crystallinity using FT-Raman spectroscopy.
    Taylor LS; Zografi G
    Pharm Res; 1998 May; 15(5):755-61. PubMed ID: 9619786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of ball-milling and cryomilling on sulfamerazine polymorphs: a quantitative study.
    Macfhionnghaile P; Hu Y; Gniado K; Curran S; Mcardle P; Erxleben A
    J Pharm Sci; 2014 Jun; 103(6):1766-78. PubMed ID: 24756899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy.
    Heinz A; Savolainen M; Rades T; Strachan CJ
    Eur J Pharm Sci; 2007 Nov; 32(3):182-92. PubMed ID: 17716878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of Milling Process on Efavirenz Solubility.
    Zaini E; Wahyu D; Octavia MD; Fitriani L
    J Pharm Bioallied Sci; 2017; 9(1):22-25. PubMed ID: 28584489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.